Prostate Cancer
Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and Protocol.
October 11, 2023
A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancer.
October 11, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
October 11, 2023
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.
October 11, 2023
Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer.
October 10, 2023
TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.
October 10, 2023
Deep Learning-Based T2-weighted MR Image Quality Assessment and Its Impact on Prostate Cancer Detection Rates.
October 10, 2023
A Canadian center's experience on whole-gland salvage therapy for radio-recurrent prostate cancer with various modalities.
October 9, 2023
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery.
October 9, 2023